Recommendations for the prevention and management of tuberculosis in patients taking infliximab

Annales de Medecine Interne

Volumn 153, Issue 7, 2002, Pages 429-431

  Salmon Ceron, Dominique ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Anti TNF ; Infliximab; Recommendations; Tuberculosis

Indexed keywords

ETHAMBUTOL; GLUCOCORTICOID; INFLIXIMAB; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; RIFATER;

CHEMOPROPHYLAXIS; CROHN DISEASE; FRANCE; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; MILIARY TUBERCULOSIS; PHYSICIAN; REVIEW; RHEUMATOID ARTHRITIS; SCREENING; TUBERCULOSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; CROHN DISEASE; DRUG THERAPY, COMBINATION; FRANCE; HUMANS; IMMUNOCOMPROMISED HOST; TUBERCULOSIS;

EID: 0036868120     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1)

1. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med, 2001; 345: 1098-104.